Helping more bladder cancer patients preserve a functioning bladder

Knight Cancer clinicians at Tuality/OHSU Cancer Center are the first in Oregon to offer a treatment option that will improve outcomes for patients with bladder cancer who cannot tolerate surgery or...

Shining a light on cancer care disparities

Image: NCI. . For some marginalized populations in the U.S., barriers preventing access to radiation therapy and other lifesaving cancer care are as insurmountable as those in the poorest nations,...

Halting resurgent prostate cancers before they spread

Q&A: Prostate cancer expert Julie Graff, M.D., explains how a new treatment option fills a void for men with resurgent tumors. When prostate cancer isn't cured by surgery or radiation, the...

What magnitude of benefit is meaningful to cancer patients?

Oncologists often use the phrase "clinically meaningful benefit" to describe the effect of an experimental treatment. But is the benefit meaningful for patients? A new paper suggests that benefit...

Cancer translated’s top blog posts of 2017

From basic science to survivorship and patient advocacy, the OHSU Knight Cancer Institute’s 'Cancer translated' blog explores new ideas and debates in cancer medicine. We sorted a year’s worth...

Radiation medicine’s evolving role in cancer care

(NCI/Rhoda Baer) Expanding treatment options for breast cancer. Enhancing immunotherapy. Addressing disparities in access to cutting-edge treatment. These are some of the highlights from ASTRO,...

When cancer drug marketing sneaks into a soap opera plot

Polycythemia vera is an uncommon blood cancer that can be controlled with long-established treatments. So it seemed more than a little suspicious to Vinay Prasad, M.D., M.P.H., when the disease took...

Outsmarting treatment-resistant prostate cancers

Aggressive prostate tumors can rapidly evolve to resist PARP inhibitors, but it may be possible to detect resistance early enough to counteract....